YE6144
YE6144 is a prototypical interferon regulatory factor 5 (IRF5) inhibitor. YE6144 selectively suppresses IRF5 activity through inhibition of IRF5 phosphorylation[1].
Product Specifications
CAS Number
[3065657-02-2]
UNSPSC
12352005
Target
IFNAR
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ye6144.html
Purity
98.37
Solubility
DMSO : 70 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CC[C@@H](CNC1=CC2=C(NN=C2/C=C/C3=CC=C(N4CCOCC4)N=N3)C=C1F)N.[H]Cl
Molecular Formula
C21H27ClFN7O
Molecular Weight
447.94
References & Citations
[1]Ban T, et al. Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease. Nat Commun. 2021 Jul 19;12 (1) :4379.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
c-erbB2 (HER-2, neu Receptor) (BSA & Azide Free) (MaxLight 550)
c-erbB2 (HER-2, neu Receptor) (BSA & Azide Free) (MaxLight 550)
TXNRD1 (Thioredoxin Reductase 1, Cytoplasmic, Thioredoxin Reductase TR1, TR, Gene Associated with Retinoic and Interferon-induced Mortality 12 Protein, Gene Associated with Retinoic and IFN-induced Mortality 12 Protein, GRIM12, GRIM-12, KM-102-derived Reductase-like Factor, KDRF)